Michel Vounatsos, as Chief Executive Officer at Biogen Idec, leads a firm with a decades-long history of developing. See sector focus and contact routes.
Michel Vounatsos, as Chief Executive Officer at Biogen Idec, leads a firm with a decades-long history of developing medicines for challenging diseases. The core of Biogen's legacy and vision is driven by scientific curiosity and a profound aspiration to help people globally. Under his leadership, the firm leverages cutting-edge science to advance potential breakthrough therapies. Their focus areas include neurology, immunology, and rare diseases, where they are dedicated to translating rigorous scientific research into first-in-class medicines. This commitment ensures Biogen continues to address unmet medical needs through innovative approaches.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Weston.
Investors like Michel Vounatsos · Full investor directory · Investor access · Company funding database